342 related articles for article (PubMed ID: 20864369)
1. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
Bielicki J; McIntyre C; Anson DS
Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
[TBL] [Abstract][Full Text] [Related]
3. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
[TBL] [Abstract][Full Text] [Related]
4. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
[TBL] [Abstract][Full Text] [Related]
5. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA.
McIntyre C; Derrick Roberts AL; Ranieri E; Clements PR; Byers S; Anson DS
Mol Genet Metab; 2008 Apr; 93(4):411-8. PubMed ID: 18248829
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
Hennig AK; Ogilvie JM; Ohlemiller KK; Timmers AM; Hauswirth WW; Sands MS
Mol Ther; 2004 Jul; 10(1):106-16. PubMed ID: 15233947
[TBL] [Abstract][Full Text] [Related]
8. Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer.
Bosch A; Perret E; Desmaris N; Trono D; Heard JM
Hum Gene Ther; 2000 May; 11(8):1139-50. PubMed ID: 10834616
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
Ross CJ; Bastedo L; Maier SA; Sands MS; Chang PL
Hum Gene Ther; 2000 Oct; 11(15):2117-27. PubMed ID: 11044913
[TBL] [Abstract][Full Text] [Related]
10. Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII.
Macsai CE; Derrick-Roberts AL; Ding X; Zarrinkalam KH; McIntyre C; Anderson PH; Anson DS; Byers S
Mol Genet Metab; 2012 Jun; 106(2):202-13. PubMed ID: 22525091
[TBL] [Abstract][Full Text] [Related]
11. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
Gao C; Sands MS; Haskins ME; Ponder KP
Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
[TBL] [Abstract][Full Text] [Related]
12. Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase.
Berges BK; Yellayi S; Karolewski BA; Miselis RR; Wolfe JH; Fraser NW
Mol Ther; 2006 May; 13(5):859-69. PubMed ID: 16515890
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
Watson GL; Sayles JN; Chen C; Elliger SS; Elliger CA; Raju NR; Kurtzman GJ; Podsakoff GM
Gene Ther; 1998 Dec; 5(12):1642-9. PubMed ID: 10023443
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
[TBL] [Abstract][Full Text] [Related]
15. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
17. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
[TBL] [Abstract][Full Text] [Related]
18. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
[TBL] [Abstract][Full Text] [Related]
19. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
[TBL] [Abstract][Full Text] [Related]
20. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase.
Taylor RM; Wolfe JH
Nat Med; 1997 Jul; 3(7):771-4. PubMed ID: 9212105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
